COVID-19 Cytokine Storm: Who's at Higher Risk of Serious Symptoms?
Patients with cancer and suppressed immune systems are at risk of severe COVID-19 infection when treated with systemic therapies, especially immunotherapies.
Stay updated with breaking news from Immunocompromised. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Patients with cancer and suppressed immune systems are at risk of severe COVID-19 infection when treated with systemic therapies, especially immunotherapies.
Findings from a CDC-supported study suggest that updated, bivalent boosters targeting recently circulating Omicron subvariants may benefit adults with immunocompromising conditions.
The White House said that without additional funding for up-to-date Covid treatments, immunocompromised individuals could potentially be at greater risk for severe disease.
Targeting primarily young children and for reasons that i have to say seem to make a lot of sense, they were masked, they weren't in groups of kids, they are not bringing home the runny nose like most preschoolers and kids in daycare. do we need to be concerned, though, for perhaps older people in the family, those who are immunocompromised in the way we were concerned about passing on covid? >> yes, and, you know, unknown fact about rsv that is not really well-recognized is that in fact there are many more adults over the age of 70 who are diagnosed with rsv and there are many more deaths ass...
It's now rare that children are hospitalized with chickenpox, and deaths from the infection in people younger than 20 have largely been eliminated. The economic benefit is calculated at $23 billion.